Genomma Lab Internacional S.A.B. de C.V
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hai… Read more
Genomma Lab Internacional S.A.B. de C.V (GNMLF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.002x
Based on the latest financial reports, Genomma Lab Internacional S.A.B. de C.V (GNMLF) has a cash flow conversion efficiency ratio of 0.002x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($18.72 Million) by net assets ($11.24 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genomma Lab Internacional S.A.B. de C.V - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Genomma Lab Internacional S.A.B. de C.V's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genomma Lab Internacional S.A.B. de C.V Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genomma Lab Internacional S.A.B. de C.V ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daktronics Inc
NASDAQ:DAKT
|
0.040x |
|
PTT OIL+RET.BUS.-NVDR- 10
F:7F80
|
N/A |
|
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP
|
-0.034x |
|
Firstsource Solutions Limited
NSE:FSL
|
0.102x |
|
Fujian Qingshan Paper Industry Co Ltd
SHG:600103
|
0.011x |
|
Criteo Sa
NASDAQ:CRTO
|
0.136x |
|
CARGOJET INC. VAR VTG
F:CJ8A
|
N/A |
|
Weichai Heavy Machinery Co Ltd
SHE:000880
|
0.131x |
Annual Cash Flow Conversion Efficiency for Genomma Lab Internacional S.A.B. de C.V (2013–2024)
The table below shows the annual cash flow conversion efficiency of Genomma Lab Internacional S.A.B. de C.V from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $522.05 Million | $3.03 Billion | 5.811x | +3308.27% |
| 2023-12-31 | $552.42 Million | $94.19 Million | 0.171x | +4.04% |
| 2022-12-31 | $520.52 Million | $85.31 Million | 0.164x | +48.05% |
| 2021-12-31 | $490.44 Million | $54.29 Million | 0.111x | -25.30% |
| 2020-12-31 | $443.78 Million | $65.76 Million | 0.148x | +195.12% |
| 2019-12-31 | $422.27 Million | $21.20 Million | 0.050x | -64.12% |
| 2018-12-31 | $377.17 Million | $52.79 Million | 0.140x | -0.33% |
| 2017-12-31 | $360.26 Million | $50.59 Million | 0.140x | -29.41% |
| 2016-12-31 | $329.73 Million | $65.59 Million | 0.199x | +8879.02% |
| 2015-12-31 | $535.50 Million | $-1.21 Million | -0.002x | -102.29% |
| 2014-12-31 | $10.50 Billion | $1.04 Billion | 0.099x | -53.30% |
| 2013-12-31 | $8.84 Billion | $1.87 Billion | 0.212x | -- |